{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Drug Label Analysis, OpenFDA"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "%matplotlib inline  \n",
    "import matplotlib.pyplot as plt\n",
    "plt.rcParams['figure.figsize'] = (10,8)\n",
    "import numpy as np\n",
    "\n",
    "import os\n",
    "import pprint\n",
    "import json\n",
    "import pandas as pd\n",
    "pprint = pprint.pprint #Set up pretty print"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_json('../data/drug_labels_rx_trimmed.json')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "## drop all columns that are 10% nan or greater\n",
    "#print(df.columns[df.isna().all()].tolist())\n",
    "#df_trim = df[df.columns[df.isna().sum()<3500]]\n",
    "#df_trim.reset_index(drop=True, inplace=True)\n",
    "#\n",
    "## reorder cols to see names\n",
    "#cols = df_trim.columns.tolist()\n",
    "#cols.remove('openfda_brand_name')\n",
    "#cols.insert(0, 'openfda_brand_name')\n",
    "#cols.remove('openfda_generic_name')\n",
    "#cols.insert(0, 'openfda_generic_name')\n",
    "#df_trim = df_trim[cols]\n",
    "#\n",
    "## calc total chars\n",
    "#df_trim['total_chars'] = 0\n",
    "## only consider string-like columns\n",
    "#for col in df_trim.select_dtypes(include='object').columns:\n",
    "#    df_trim['total_chars'] += np.nan_to_num(df_trim[col].str.len())\n",
    "#    \n",
    "## make json\n",
    "#df_trim.to_json('../data/drug_labels_rx_trimmed.json') "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "68689.4672"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# estimate amazon pricing\n",
    "df['total_chars'].sum()/100 * 0.01 # $70,000 for the prescription only shiz\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>openfda_generic_name</th>\n",
       "      <th>openfda_brand_name</th>\n",
       "      <th>adverse_reactions</th>\n",
       "      <th>clinical_pharmacology</th>\n",
       "      <th>contraindications</th>\n",
       "      <th>description</th>\n",
       "      <th>dosage_and_administration</th>\n",
       "      <th>effective_time</th>\n",
       "      <th>how_supplied</th>\n",
       "      <th>id</th>\n",
       "      <th>indications_and_usage</th>\n",
       "      <th>openfda_application_number</th>\n",
       "      <th>openfda_manufacturer_name</th>\n",
       "      <th>openfda_package_ndc</th>\n",
       "      <th>openfda_product_ndc</th>\n",
       "      <th>openfda_product_type</th>\n",
       "      <th>openfda_route</th>\n",
       "      <th>openfda_rxcui</th>\n",
       "      <th>openfda_spl_id</th>\n",
       "      <th>openfda_spl_set_id</th>\n",
       "      <th>openfda_substance_name</th>\n",
       "      <th>openfda_unii</th>\n",
       "      <th>package_label_principal_display_panel</th>\n",
       "      <th>set_id</th>\n",
       "      <th>spl_product_data_elements</th>\n",
       "      <th>version</th>\n",
       "      <th>total_chars</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>LEVOCETIRIZINE DIHYDROCHLORIDE</td>\n",
       "      <td>levocetirizine dihydrochloride</td>\n",
       "      <td>6 ADVERSE REACTIONS Use of levocetirizine dihy...</td>\n",
       "      <td>12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Act...</td>\n",
       "      <td>4 CONTRAINDICATIONS The use of levocetirizine ...</td>\n",
       "      <td>11 DESCRIPTION Levocetirizine dihydrochloride,...</td>\n",
       "      <td>2 DOSAGE AND ADMINISTRATION Levocetirizine dih...</td>\n",
       "      <td>20160301</td>\n",
       "      <td>16 HOW SUPPLIED/STORAGE AND HANDLING Levocetir...</td>\n",
       "      <td>b84ccb27-9c52-43b9-9a46-8f52a571045e</td>\n",
       "      <td>1 INDICATIONS AND USAGE Levocetirizine dihydro...</td>\n",
       "      <td>ANDA203646</td>\n",
       "      <td>Proficient Rx LP</td>\n",
       "      <td>[63187-663-60, 63187-663-90, 63187-663-30]</td>\n",
       "      <td>63187-663</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>ORAL</td>\n",
       "      <td>855172</td>\n",
       "      <td>b84ccb27-9c52-43b9-9a46-8f52a571045e</td>\n",
       "      <td>b84ccb27-9c52-43b9-9a46-8f52a571045e</td>\n",
       "      <td>LEVOCETIRIZINE DIHYDROCHLORIDE</td>\n",
       "      <td>SOD6A38AGA</td>\n",
       "      <td>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL NDC 6318...</td>\n",
       "      <td>b84ccb27-9c52-43b9-9a46-8f52a571045e</td>\n",
       "      <td>levocetirizine dihydrochloride levocetirizine ...</td>\n",
       "      <td>1</td>\n",
       "      <td>25488</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>LISINOPRIL</td>\n",
       "      <td>Lisinopril</td>\n",
       "      <td>6 ADVERSE REACTIONS Common adverse reactions (...</td>\n",
       "      <td>12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Act...</td>\n",
       "      <td>4 CONTRAINDICATIONS Lisinopril is contraindica...</td>\n",
       "      <td>11 DESCRIPTION Lisinopril is an oral long-acti...</td>\n",
       "      <td>2 DOSAGE AND ADMINISTRATION Hypertension: Init...</td>\n",
       "      <td>20160627</td>\n",
       "      <td>16 HOW SUPPLIED/STORAGE AND HANDLING Lisinopri...</td>\n",
       "      <td>d4004fc6-9440-4480-be75-8baa53b96090</td>\n",
       "      <td>1 INDICATIONS AND USAGE Lisinopril is an angio...</td>\n",
       "      <td>ANDA075743</td>\n",
       "      <td>Aphena Pharma Solutions - Tennessee, LLC</td>\n",
       "      <td>[43353-993-92, 43353-993-45, 43353-993-53, 433...</td>\n",
       "      <td>43353-993</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>ORAL</td>\n",
       "      <td>314077</td>\n",
       "      <td>d4004fc6-9440-4480-be75-8baa53b96090</td>\n",
       "      <td>4d0d04a6-6010-4f2a-b17e-6c7a856d2056</td>\n",
       "      <td>LISINOPRIL</td>\n",
       "      <td>E7199S1YWR</td>\n",
       "      <td>PRINCIPAL DISPLAY PANEL - 20 mg NDC 43353-993 ...</td>\n",
       "      <td>4d0d04a6-6010-4f2a-b17e-6c7a856d2056</td>\n",
       "      <td>Lisinopril Lisinopril LISINOPRIL LISINOPRIL AN...</td>\n",
       "      <td>1</td>\n",
       "      <td>24413</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>CHOLESTYRAMINE</td>\n",
       "      <td>Cholestyramine</td>\n",
       "      <td>ADVERSE REACTIONS The most common adverse reac...</td>\n",
       "      <td>CLINICAL PHARMACOLOGY Cholesterol is probably ...</td>\n",
       "      <td>CONTRAINDICATIONS Cholestyramine for Oral Susp...</td>\n",
       "      <td>DESCRIPTION Cholestyramine for Oral Suspension...</td>\n",
       "      <td>DOSAGE AND ADMINISTRATION The recommended star...</td>\n",
       "      <td>20180504</td>\n",
       "      <td>HOW SUPPLIED Cholestyramine for Oral Suspensio...</td>\n",
       "      <td>e0d44fe4-f7b8-4069-8e0e-b8920960b23f</td>\n",
       "      <td>INDICATIONS AND USAGE 1) Cholestyramine for Or...</td>\n",
       "      <td>ANDA074557</td>\n",
       "      <td>Upsher-Smith Laboratories, Inc.</td>\n",
       "      <td>[0245-0536-37, 0245-0536-60]</td>\n",
       "      <td>0245-0536</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>ORAL</td>\n",
       "      <td>848943</td>\n",
       "      <td>e0d44fe4-f7b8-4069-8e0e-b8920960b23f</td>\n",
       "      <td>aa1e8007-ec11-4a08-a343-b5b0645695a1</td>\n",
       "      <td>CHOLESTYRAMINE</td>\n",
       "      <td>4B33BGI082</td>\n",
       "      <td>PRINCIPAL DISPLAY PANEL NDC 0245-0536-37 Chole...</td>\n",
       "      <td>aa1e8007-ec11-4a08-a343-b5b0645695a1</td>\n",
       "      <td>Cholestyramine Cholestyramine CHOLESTYRAMINE C...</td>\n",
       "      <td>6</td>\n",
       "      <td>15305</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>WARFARIN SODIUM</td>\n",
       "      <td>Warfarin Sodium</td>\n",
       "      <td>6 ADVERSE REACTIONS The following serious adve...</td>\n",
       "      <td>12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Act...</td>\n",
       "      <td>4 CONTRAINDICATIONS Warfarin sodium tablets, U...</td>\n",
       "      <td>11 DESCRIPTION Warfarin sodium tablets contain...</td>\n",
       "      <td>2 DOSAGE AND ADMINISTRATION Individualize dosi...</td>\n",
       "      <td>20171021</td>\n",
       "      <td>16 HOW SUPPLIED/STORAGE AND HANDLING Warfarin ...</td>\n",
       "      <td>4e72832d-fbd7-4bf3-946c-6aeec550d345</td>\n",
       "      <td>1 INDICATIONS AND USAGE Warfarin sodium tablet...</td>\n",
       "      <td>ANDA040301</td>\n",
       "      <td>Taro Pharmaceuticals U.S.A., Inc.</td>\n",
       "      <td>[51672-4027-7, 51672-4027-3, 51672-4027-0, 516...</td>\n",
       "      <td>[51672-4033, 51672-4032, 51672-4031, 51672-403...</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>ORAL</td>\n",
       "      <td>[855332, 855288, 855344, 855318, 855324, 85530...</td>\n",
       "      <td>4e72832d-fbd7-4bf3-946c-6aeec550d345</td>\n",
       "      <td>8ad881e0-ca41-42ad-9d7d-eb85b3a30af0</td>\n",
       "      <td>WARFARIN SODIUM</td>\n",
       "      <td>6153CWM0CL</td>\n",
       "      <td>[PRINCIPAL DISPLAY PANEL - 1 mg Tablet Bottle ...</td>\n",
       "      <td>8ad881e0-ca41-42ad-9d7d-eb85b3a30af0</td>\n",
       "      <td>Warfarin Sodium Warfarin Sodium Warfarin Sodiu...</td>\n",
       "      <td>8</td>\n",
       "      <td>27589</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1000</th>\n",
       "      <td>LEVOFLOXACIN</td>\n",
       "      <td>LEVOFLOXACIN</td>\n",
       "      <td>6.1 Serious and Otherwise Important Adverse Re...</td>\n",
       "      <td>12.1 Mechanism of Action Levofloxacin is a mem...</td>\n",
       "      <td>Levofloxacin is contraindicated in persons wit...</td>\n",
       "      <td>[levofloxacinfigure1] Levofloxacin, USP is a s...</td>\n",
       "      <td>2.1 Dosage in Adult Patients with Normal Renal...</td>\n",
       "      <td>20180315</td>\n",
       "      <td>16.1 Levofloxacin Tablets, USP •Levofloxacin T...</td>\n",
       "      <td>677628d1-858c-7a4e-e053-2a91aa0a099a</td>\n",
       "      <td>Levofloxacin tablets are indicated for the tre...</td>\n",
       "      <td>ANDA076890</td>\n",
       "      <td>DIRECT RX</td>\n",
       "      <td>61919-440-14</td>\n",
       "      <td>61919-440</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>ORAL</td>\n",
       "      <td>311296</td>\n",
       "      <td>677628d1-858c-7a4e-e053-2a91aa0a099a</td>\n",
       "      <td>4f40d5fa-ebcc-516c-e054-00144ff8d46c</td>\n",
       "      <td>LEVOFLOXACIN</td>\n",
       "      <td>6GNT3Y5LMF</td>\n",
       "      <td>440-14</td>\n",
       "      <td>4f40d5fa-ebcc-516c-e054-00144ff8d46c</td>\n",
       "      <td>LEVOFLOXACIN LEVOFLOXACIN CROSCARMELLOSE SODIU...</td>\n",
       "      <td>2</td>\n",
       "      <td>47493</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                openfda_generic_name              openfda_brand_name  \\\n",
       "0     LEVOCETIRIZINE DIHYDROCHLORIDE  levocetirizine dihydrochloride   \n",
       "1                         LISINOPRIL                      Lisinopril   \n",
       "10                    CHOLESTYRAMINE                  Cholestyramine   \n",
       "100                  WARFARIN SODIUM                 Warfarin Sodium   \n",
       "1000                    LEVOFLOXACIN                    LEVOFLOXACIN   \n",
       "\n",
       "                                      adverse_reactions  \\\n",
       "0     6 ADVERSE REACTIONS Use of levocetirizine dihy...   \n",
       "1     6 ADVERSE REACTIONS Common adverse reactions (...   \n",
       "10    ADVERSE REACTIONS The most common adverse reac...   \n",
       "100   6 ADVERSE REACTIONS The following serious adve...   \n",
       "1000  6.1 Serious and Otherwise Important Adverse Re...   \n",
       "\n",
       "                                  clinical_pharmacology  \\\n",
       "0     12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Act...   \n",
       "1     12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Act...   \n",
       "10    CLINICAL PHARMACOLOGY Cholesterol is probably ...   \n",
       "100   12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Act...   \n",
       "1000  12.1 Mechanism of Action Levofloxacin is a mem...   \n",
       "\n",
       "                                      contraindications  \\\n",
       "0     4 CONTRAINDICATIONS The use of levocetirizine ...   \n",
       "1     4 CONTRAINDICATIONS Lisinopril is contraindica...   \n",
       "10    CONTRAINDICATIONS Cholestyramine for Oral Susp...   \n",
       "100   4 CONTRAINDICATIONS Warfarin sodium tablets, U...   \n",
       "1000  Levofloxacin is contraindicated in persons wit...   \n",
       "\n",
       "                                            description  \\\n",
       "0     11 DESCRIPTION Levocetirizine dihydrochloride,...   \n",
       "1     11 DESCRIPTION Lisinopril is an oral long-acti...   \n",
       "10    DESCRIPTION Cholestyramine for Oral Suspension...   \n",
       "100   11 DESCRIPTION Warfarin sodium tablets contain...   \n",
       "1000  [levofloxacinfigure1] Levofloxacin, USP is a s...   \n",
       "\n",
       "                              dosage_and_administration  effective_time  \\\n",
       "0     2 DOSAGE AND ADMINISTRATION Levocetirizine dih...        20160301   \n",
       "1     2 DOSAGE AND ADMINISTRATION Hypertension: Init...        20160627   \n",
       "10    DOSAGE AND ADMINISTRATION The recommended star...        20180504   \n",
       "100   2 DOSAGE AND ADMINISTRATION Individualize dosi...        20171021   \n",
       "1000  2.1 Dosage in Adult Patients with Normal Renal...        20180315   \n",
       "\n",
       "                                           how_supplied  \\\n",
       "0     16 HOW SUPPLIED/STORAGE AND HANDLING Levocetir...   \n",
       "1     16 HOW SUPPLIED/STORAGE AND HANDLING Lisinopri...   \n",
       "10    HOW SUPPLIED Cholestyramine for Oral Suspensio...   \n",
       "100   16 HOW SUPPLIED/STORAGE AND HANDLING Warfarin ...   \n",
       "1000  16.1 Levofloxacin Tablets, USP •Levofloxacin T...   \n",
       "\n",
       "                                        id  \\\n",
       "0     b84ccb27-9c52-43b9-9a46-8f52a571045e   \n",
       "1     d4004fc6-9440-4480-be75-8baa53b96090   \n",
       "10    e0d44fe4-f7b8-4069-8e0e-b8920960b23f   \n",
       "100   4e72832d-fbd7-4bf3-946c-6aeec550d345   \n",
       "1000  677628d1-858c-7a4e-e053-2a91aa0a099a   \n",
       "\n",
       "                                  indications_and_usage  \\\n",
       "0     1 INDICATIONS AND USAGE Levocetirizine dihydro...   \n",
       "1     1 INDICATIONS AND USAGE Lisinopril is an angio...   \n",
       "10    INDICATIONS AND USAGE 1) Cholestyramine for Or...   \n",
       "100   1 INDICATIONS AND USAGE Warfarin sodium tablet...   \n",
       "1000  Levofloxacin tablets are indicated for the tre...   \n",
       "\n",
       "     openfda_application_number                 openfda_manufacturer_name  \\\n",
       "0                    ANDA203646                          Proficient Rx LP   \n",
       "1                    ANDA075743  Aphena Pharma Solutions - Tennessee, LLC   \n",
       "10                   ANDA074557           Upsher-Smith Laboratories, Inc.   \n",
       "100                  ANDA040301         Taro Pharmaceuticals U.S.A., Inc.   \n",
       "1000                 ANDA076890                                 DIRECT RX   \n",
       "\n",
       "                                    openfda_package_ndc  \\\n",
       "0            [63187-663-60, 63187-663-90, 63187-663-30]   \n",
       "1     [43353-993-92, 43353-993-45, 43353-993-53, 433...   \n",
       "10                         [0245-0536-37, 0245-0536-60]   \n",
       "100   [51672-4027-7, 51672-4027-3, 51672-4027-0, 516...   \n",
       "1000                                       61919-440-14   \n",
       "\n",
       "                                    openfda_product_ndc  \\\n",
       "0                                             63187-663   \n",
       "1                                             43353-993   \n",
       "10                                            0245-0536   \n",
       "100   [51672-4033, 51672-4032, 51672-4031, 51672-403...   \n",
       "1000                                          61919-440   \n",
       "\n",
       "         openfda_product_type openfda_route  \\\n",
       "0     HUMAN PRESCRIPTION DRUG          ORAL   \n",
       "1     HUMAN PRESCRIPTION DRUG          ORAL   \n",
       "10    HUMAN PRESCRIPTION DRUG          ORAL   \n",
       "100   HUMAN PRESCRIPTION DRUG          ORAL   \n",
       "1000  HUMAN PRESCRIPTION DRUG          ORAL   \n",
       "\n",
       "                                          openfda_rxcui  \\\n",
       "0                                                855172   \n",
       "1                                                314077   \n",
       "10                                               848943   \n",
       "100   [855332, 855288, 855344, 855318, 855324, 85530...   \n",
       "1000                                             311296   \n",
       "\n",
       "                            openfda_spl_id  \\\n",
       "0     b84ccb27-9c52-43b9-9a46-8f52a571045e   \n",
       "1     d4004fc6-9440-4480-be75-8baa53b96090   \n",
       "10    e0d44fe4-f7b8-4069-8e0e-b8920960b23f   \n",
       "100   4e72832d-fbd7-4bf3-946c-6aeec550d345   \n",
       "1000  677628d1-858c-7a4e-e053-2a91aa0a099a   \n",
       "\n",
       "                        openfda_spl_set_id          openfda_substance_name  \\\n",
       "0     b84ccb27-9c52-43b9-9a46-8f52a571045e  LEVOCETIRIZINE DIHYDROCHLORIDE   \n",
       "1     4d0d04a6-6010-4f2a-b17e-6c7a856d2056                      LISINOPRIL   \n",
       "10    aa1e8007-ec11-4a08-a343-b5b0645695a1                  CHOLESTYRAMINE   \n",
       "100   8ad881e0-ca41-42ad-9d7d-eb85b3a30af0                 WARFARIN SODIUM   \n",
       "1000  4f40d5fa-ebcc-516c-e054-00144ff8d46c                    LEVOFLOXACIN   \n",
       "\n",
       "     openfda_unii              package_label_principal_display_panel  \\\n",
       "0      SOD6A38AGA  PACKAGE LABEL-PRINCIPAL DISPLAY PANEL NDC 6318...   \n",
       "1      E7199S1YWR  PRINCIPAL DISPLAY PANEL - 20 mg NDC 43353-993 ...   \n",
       "10     4B33BGI082  PRINCIPAL DISPLAY PANEL NDC 0245-0536-37 Chole...   \n",
       "100    6153CWM0CL  [PRINCIPAL DISPLAY PANEL - 1 mg Tablet Bottle ...   \n",
       "1000   6GNT3Y5LMF                                             440-14   \n",
       "\n",
       "                                    set_id  \\\n",
       "0     b84ccb27-9c52-43b9-9a46-8f52a571045e   \n",
       "1     4d0d04a6-6010-4f2a-b17e-6c7a856d2056   \n",
       "10    aa1e8007-ec11-4a08-a343-b5b0645695a1   \n",
       "100   8ad881e0-ca41-42ad-9d7d-eb85b3a30af0   \n",
       "1000  4f40d5fa-ebcc-516c-e054-00144ff8d46c   \n",
       "\n",
       "                              spl_product_data_elements  version  total_chars  \n",
       "0     levocetirizine dihydrochloride levocetirizine ...        1        25488  \n",
       "1     Lisinopril Lisinopril LISINOPRIL LISINOPRIL AN...        1        24413  \n",
       "10    Cholestyramine Cholestyramine CHOLESTYRAMINE C...        6        15305  \n",
       "100   Warfarin Sodium Warfarin Sodium Warfarin Sodiu...        8        27589  \n",
       "1000  LEVOFLOXACIN LEVOFLOXACIN CROSCARMELLOSE SODIU...        2        47493  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "with pd.option_context('display.max_columns', 160):\n",
    "    display(df.head())\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(35668, 27)"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_trim"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.query('openfda_product_type == \"HUMAN OTC DRUG\"').total_chars.sum()/100*0.01"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "df.query('total_chars < 50000').total_chars.sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.total_chars.hist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.query('openfda_product_type == \"HUMAN PRESCRIPTION DRUG\"').total_chars.sum()/100*0.01"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df[['openfda_brand_name', 'openfda_product_type']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "with pd.option_context('display.max_rows', 160):\n",
    "    print(df.loc[99995])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_rx = df.query('openfda_product_type == \"HUMAN PRESCRIPTION DRUG\"')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_rx.to_csv('../data/drug_labels_rx_only.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
